Jeremy Ratcliff
Overview
Explore the profile of Jeremy Ratcliff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratcliff J
NAR Genom Bioinform
. 2024 Sep;
6(3):lqae129.
PMID: 39296932
Novel applications of language models in genomics promise to have a large impact on the field. The megaDNA model is the first publicly available generative model for creating synthetic viral...
2.
Jay C, Adland E, Csala A, Lim N, Longet S, Ogbe A, et al.
Front Immunol
. 2023 Nov;
14:1248630.
PMID: 37942333
Introduction: The key to understanding the COVID-19 correlates of protection is assessing vaccine-induced immunity in different demographic groups. Young people are at a lower risk of COVID-19 mortality, females are...
3.
Ratcliff J, Simmonds P
Curr Opin Virol
. 2023 Apr;
60:101326.
PMID: 37031485
Following spillover, viruses must adapt to new selection pressures exerted by antiviral responses in their new hosts. In mammals, cellular defense mechanisms often include viral nucleic acid editing pathways mediated...
4.
Jay C, Ratcliff J, Turtle L, Goulder P, Klenerman P
Front Immunol
. 2023 Feb;
14:1092910.
PMID: 36776841
The factors determining whether infection will occur following exposure to SARS-CoV-2 remain elusive. Certain SARS-CoV-2-exposed individuals mount a specific T-cell response but fail to seroconvert, representing a population that may...
5.
Dong E, Ratcliff J, Goyea T, Katz A, Lau R, Ng T, et al.
Lancet Infect Dis
. 2022 Sep;
22(12):e370-e376.
PMID: 36057267
On Jan 22, 2020, a day after the USA reported its first COVID-19 case, the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE) launched the first global...
6.
Williams S, Ratcliff J, Nguyen D, Simmonds P, Harvala H
Transfus Med
. 2022 Jun;
32(5):402-409.
PMID: 35751630
Background And Objectives: Infections with human parvovirus B19 (B19V) are transmissible by blood components and plasma-derived medicines. The European Pharmacopoeia regulates maximum levels of virus allowed in manufacturers' plasma pools....
7.
McNaughton A, Paton R, Edmans M, Youngs J, Wellens J, Phalora P, et al.
JCI Insight
. 2022 May;
7(13).
PMID: 35608920
The role of immune responses to previously seen endemic coronavirus epitopes in severe acute respiratory coronavirus 2 (SARS-CoV-2) infection and disease progression has not yet been determined. Here, we show...
8.
Ratcliff J, Al-Beidh F, Bibi S, Bonsall D, Clemens S, Estcourt L, et al.
J Clin Microbiol
. 2022 Mar;
60(4):e0228321.
PMID: 35321556
Tools to detect SARS-CoV-2 variants of concern and track the ongoing evolution of the virus are necessary to support public health efforts and the design and evaluation of novel COVID-19...
9.
Nguyen D, Xiao J, Simmonds P, Lamikanra A, Odon V, Ratcliff J, et al.
J Infect Dis
. 2021 Nov;
225(6):971-976.
PMID: 34751775
We compared neutralizing antibody titers of convalescent samples collected before and after the emergence of novel strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), against the wild-type virus and...
10.
Clemens S, Folegatti P, Emary K, Weckx L, Ratcliff J, Bibi S, et al.
Nat Commun
. 2021 Oct;
12(1):5861.
PMID: 34615860
Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19...